BioLamina
Sundbyberg, Sweden· Est. 2008
BioLamina offers laminin cell culture matrix, the only laminins that are the original, full length, human recombinant laminins on the market.
Private Company
Total funding raised: $34M
About
BioLamina offers laminin cell culture matrix, the only laminins that are the original, full length, human recombinant laminins on the market.
Cell TherapyRegenerative Medicine
Funding History
5Total raised:$34M
Series B$12MMar 15, 2020
Series B$10MJun 15, 2018
Series A$6.5MSep 15, 2016
Series A$5.5MJun 15, 2015